| 000 | 01385 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511213029.0 | ||
| 264 | 0 | _c19911101 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.35.8.1596 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, H | |
| 245 | 0 | 0 |
_aProlonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cAug 1991 |
||
| 300 |
_a1596-600 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Stem _xmicrobiology |
| 650 | 0 | 4 | _aCidofovir |
| 650 | 0 | 4 |
_aCytosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEncephalitis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
| 650 | 0 | 4 |
_aHerpes Simplex _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aOrganophosphonates |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aPremedication |
| 700 | 1 | _aDatema, R | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 35 _gno. 8 _gp. 1596-600 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.35.8.1596 _zAvailable from publisher's website |
| 999 |
_c1935528 _d1935528 |
||